Botfet / Company detail

NBIX

universe

Neurocrine Biosciences, Inc.

biotech

Moat score54out of 100

The numbers

Financial metrics

Quality gate and thesis context

Roic10.8%

Gross Margin98.2%

Revenue Cagr26.0%

Fcf Conversion156.4%

Fcf Yield5.1%

Interest Coverage0.0x

Market Cap B$14.7B

Pe20.2

Quality PassPass

Founder LedNo

Thesis AlignedYes

Moat Quant54

Why it may endure

Moat breakdown

Quant: 54 · Curator: 0

Market Share Stability6

Network Effects6

Pricing Power20

Regulatory Moat16

Switching Costs6

Conviction0/10

Leadership0/10

Vision0/10

← Back to the full screener